Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 16,146 | 0 | 0 | 0 | 0 |
| Cost of Goods | 475 | N/A | N/A | N/A | N/A |
| Gross Profit | 15,671 | N/A | N/A | N/A | N/A |
| Operating Expenses | 105,606 | 82,196 | 123,481 | 69,717 | 12,894 |
| Operating Income | -89,460 | -82,196 | -123,481 | -69,717 | -12,894 |
| Other Income | 9,965 | 8,406 | 2,764 | -6,258 | 66 |
| Pre-tax Income | -79,495 | -73,790 | -120,717 | -75,975 | -12,828 |
| Income Tax | -2,164 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -77,331 | -73,790 | -120,717 | -75,975 | -12,828 |
| Net Income | $-77,331 | $-73,790 | $-120,717 | $-75,975 | $-12,828 |
| EPS Basic Total Ops | -1.32 | -1.85 | -3.65 | -8.95 | -12.45 |
| EPS Basic Continuous Ops | -1.32 | -1.85 | -3.65 | -8.95 | -12.44 |
| EPS Diluted Total Ops | -1.32 | -1.85 | -3.65 | -8.95 | -12.45 |
| EPS Diluted Continuous Ops | -1.32 | -1.85 | -3.65 | -8.95 | -12.44 |
| EPS Diluted Before Non-Recurring Items | -1.04 | -1.85 | -3.65 | -8.95 | N/A |
| EBITDA(a) | $-92,587 | $-85,057 | $-122,772 | $-69,070 | $-12,425 |